Neurotechnology developers work at the intersection of neuroscience and engineering, creating innovative tools that enhance our understanding of the brain and improve treatments for neurological conditions. They design and implement technologies such as brain-computer interfaces (BCIs), neural prosthetics, and neuroimaging devices to monitor, diagnose, and treat neurological disorders. These specialists collaborate with neuroscientists, clinicians, and biomedical engineers to develop devices that can interface directly with the brain, providing patients with the ability to control prosthetic limbs or communicate through thought. Neurotechnology developers are also involved in the creation of advanced neuroimaging systems, which allow for detailed, real-time observation of brain activity in patients with conditions like epilepsy or Parkinson’s disease. Their work extends to innovations in neural stimulation therapies, such as transcranial magnetic stimulation (TMS), which is used to treat mood disorders, pain, and neurological rehabilitation. With rapid advancements in artificial intelligence and machine learning, neurotechnology developers are increasingly leveraging these technologies to improve diagnostics, optimize treatment protocols, and provide personalized care. They play a pivotal role in advancing the field of neuroengineering, with the goal of improving the quality of life for individuals with neurological disorders through cutting-edge technologies.
Title : A case of vile vindictive primary CNS vasculitis
George Diaz, Memorial Healthcare Systems, United States
Title : Novel important cellular responses, signaling mechanisms and therapeutic options in vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : The role of beliefs, perception, and behavioural patterns in the evolution of psychophysical disorders
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : How have we eliminated infection: From the bone to brain?
Thomas J Webster, Interstellar Therapeutics, United States
Title : Cervical stenosis-induced chronic cerebrospinal fluid flow restriction as a contributing cause of dementia
Joe Sam Robinson, Mercer University, United States